This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Global Contact Lenses And Solutions Industry

Advanced EyeCare Carries CIBA Vision's New Contact Lens

Technology II-48

RevolutionEYES Offers New Bifocal Contact Lens II-48

Alcon Unveils Opti-Free GP Contact Lens Solution II-48

UltraVision Introduces UltraWave® SiH II-49

Contamac Introduces New GP Contact Lens Materials II-49

Art Optical Introduces New Thinsite2 Lens II-49

CooperVision Launches New Biofinity Toric Lens II-49

Alcon Unveils +3.0 Add Power AcrySof® ReSTOR® Aspheric

Intraocular Lens II-49

Bausch & Lomb Launches Crystalens® HD Intraocular Lens II-50

Unilens Vision Rolls Out C-VUE® Advanced™ Custom Toric Lens II-50

Unilens Vision Unveils C-VUE 1 Day Aspheric Single Vision

Contact Lens II-50

CooperVision Extends Parameters of Proclear® 1-Day Contact Lenses II-50

CooperVision Extends Sphere Powers of Proclear® Sphere Contact

Lenses II-51

CooperVision Extends Parameters of Biofinity® Silicone

Hydrogel Contact Lenses II-51

Bausch & Lomb to Introduce SofLens® Daily Disposable Contact

Lenses II-51

UltraVision to Unveil KeraSoft®IC Lenses II-52

Bausch & Lomb to Introduce SofLens® Daily Disposable Contact

Lenses II-52

UltraVision to Unveil KeraSoft®IC Lenses II-52

Bausch & Lomb to Introduce SofLens® Daily Disposable Contact

Lenses II-53

UltraVision to Unveil KeraSoft®IC Lenses II-53

Bausch & Lomb to Introduce SofLens® Daily Disposable Contact

Lenses II-54

UltraVision to Unveil KeraSoft®IC Lenses II-54

Alcon Receives FDA Approval for AcrySof® IQ ReSTOR®

Intraocular Lens II-54

Bausch & Lomb Secures Approval for Akreos™ Advanced Optics

Aspheric Lens II-55

CooperVision Secures FDA Approval for Biofinity® Silicone

Hydrogel Contact Lenses II-55

Hoya Surgical Optics Wins Approval for iSpheric™ Model YA-60BB

Intraocular Lens II-55

SynergEyes Inc. Unveils Post-Surgical Hybrid Contact Lens II-55

5. RECENT INDUSTRY ACTIVITY II-56

Bruno Pharmaceuticals Takes Over Safilens® II-56

WellPoint to Take Over 1-800 CONTACTS II-56

OcuSoft Inks Agreement with Essentia Pharma II-56

Essilor International Takes Over Majority Stake in Jiangsu

Youli Optics and Jiangsu Seeworld Optical II-56

Menicon Acquires W.I. System II-56

Alcon Merges Operations with Novartis II-57

GP Specialists Takes Over American BioCurve™ II-57

6 of 22

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs